These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6657043)

  • 21. Enhanced linear growth responses in hypopituitary dwarfs treated with growth hormone plus androgen versus growth hormone alone.
    MacGillivray MH; Kolotkin M; Munschauer RW
    Pediatr Res; 1974 Feb; 8(2):103-8. PubMed ID: 4810507
    [No Abstract]   [Full Text] [Related]  

  • 22. Growth response of 26 children with short stature given human growth hormone.
    Tanner JM; Whitehouse RH
    Br Med J; 1967 Apr; 2(5544):69-75. PubMed ID: 6020851
    [No Abstract]   [Full Text] [Related]  

  • 23. [Results of thyroid function tests before and during treatment with homologous somatotropin in patients with hypophyseal-hypothalamic growth disorders].
    Willgerodt H; Lässker G
    Cesk Pediatr; 1972 Oct; 27(10):476-7. PubMed ID: 5078506
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pituitary dwarfism. Our experience with human growth hormone treatment].
    Sanz Moreno J; López-Linares M; Arrieta F; Ramos F; Herrera Pombo JL
    Rev Clin Esp; 1981 Oct; 163(2):105-10. PubMed ID: 7330341
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapy of hypophyseal-hypothalamic nanism with somatotropic hormone].
    Loeschke A
    Clin Ter; 1970 Jun; 53(6):479-90. PubMed ID: 5527426
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children, with growth hormone deficiency, low birthweight, inherited smallness, Turner's syndrome, and other complaints.
    Tanner JM; Whitehouse RH; Hughes PC; Vince FP
    Arch Dis Child; 1971 Dec; 46(250):745-82. PubMed ID: 5288779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The investigation and treatment of pituitary dwarfism: preliminary experience with human growth hormone.
    Burger HG; Catt K; Connelly JF; Hudson B; Martin FI; Melick R; Taft HP; Wettenhall HB
    Med J Aust; 1967 Apr; 1(15):739-42. PubMed ID: 6024145
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of idiopathic pituitary dwarfism with human growth hormone (KABI).
    Shizume K; Demura R; Ichikawa K; Takano K; Odagiri E
    Endocrinol Jpn; 1974 Dec; 21(6):485-92. PubMed ID: 4377128
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical application of growth hormone and therapeutic results in pituitary dwarfism in Japan].
    Shizume K
    Nihon Rinsho; 1971 Jul; 29(7):1761-7. PubMed ID: 5170119
    [No Abstract]   [Full Text] [Related]  

  • 30. Growth promoters in humans.
    Burns HJ
    Proc Nutr Soc; 1990 Oct; 49(3):467-72. PubMed ID: 2080178
    [No Abstract]   [Full Text] [Related]  

  • 31. [Monomeric and dimeric forms of human somatotropin in the treatment of children with pituitary dwarfism].
    Grodecka B; Starzec A; Korbecki M; Rybakowa M; Bittel-Dobrzyńska N; Romer T
    Endokrynol Pol; 1980; 31(1):19-32. PubMed ID: 7363867
    [No Abstract]   [Full Text] [Related]  

  • 32. [Metabolic changes in patientss with pituitary nanism under the influence of Sotropin H].
    Némethová V; Németh S; Vigas M
    Cesk Pediatr; 1972 Nov; 27(11):532-3. PubMed ID: 4564463
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of growth acceleration of pituitary dwarfs treated with anabolic steroid and thyroid hormone with normal growth spurt.
    Harada Y; Okada Y; Hikita T; Ninomiya T; Ishihara Y
    Acta Endocrinol (Copenh); 1973 Oct; 74(2):237-49. PubMed ID: 4355073
    [No Abstract]   [Full Text] [Related]  

  • 34. [Results of the treatment of somatotropin-deficient dwarfism in children with Somatohorm (Biomed) and Crescormon (Kabi-Vitrum)].
    Rybakowa M; Sołtysik-Wilk E; Pleti M
    Folia Med Cracov; 1988; 29(3-4):121-6. PubMed ID: 3077128
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative action of human growth hormone and synthetic anabolics on the growth rate in hypothalamo-hypophyseal dwarfism].
    Royer P; Rappaport R; Elsair J; Ciric S; Cachin O
    Ann Endocrinol (Paris); 1970; 31(1):121-30. PubMed ID: 4314692
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diagnosis and treatment of acromegaly and pituitary dwarfism].
    Shizume K
    Nihon Naibunpi Gakkai Zasshi; 1968 Dec; 44(9):1001-6. PubMed ID: 5752194
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diagnosis and treatment of pituitary dwarfism].
    Hibi I; Tanae A; Koda N; Nagabuchi S
    Horumon To Rinsho; 1984 Jan; 32(1):9-14. PubMed ID: 6325053
    [No Abstract]   [Full Text] [Related]  

  • 38. The combined effect of growth hormone and methandrostenolone on the linear growth of patients with multiple pituitary hormone deficiencies.
    Pertzelan A; Blum I; Grunebaum M; Laron Z
    Clin Endocrinol (Oxf); 1977 Apr; 6(4):271-6. PubMed ID: 193658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of growth hormone in hypothalamo-hypophyseal dwarfism. Study of the antigenic action of a partially hydrolyzed bovine growth hormone preparation].
    Silberschmidt M; Elsair J; Hitzig WH; Royer P
    Arch Fr Pediatr; 1967 Oct; 24(8):881-90. PubMed ID: 5626124
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical experience in the treatment of idiopathic pituitary dwarfism with human growth hormone (KABI)].
    Hibi I; Tanae A; Ozeki T
    Horumon To Rinsho; 1974 May; 22(5):627-36. PubMed ID: 4472959
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.